IBIO
LIVE

Serial Number

98091758

Owner

IBIO, INC.

Attorney

Daniel Chalker

First Use Date

Jul 11, 2023

Filing Date

Jul 19, 2023

Add to watchlist:

No watchlists yet
View on USPTO

IBIO Trademark

Serial Number: 98091758 • Registration: 7511691

IBIO is a trademark filed by IBIO, INC. on July 19, 2023. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

IBIO, INC. (10 trademarks)

8800 HSC PARKWAY
BRYAN, TX 77807

Entity Type: 03

Trademark Details

Filing Date

July 19, 2023

Registration Date

September 24, 2024

First Use Anywhere

July 11, 2023

First Use in Commerce

July 11, 2023

Published for Opposition

July 9, 2024

Goods & Services

Pharmaceutical peptide, protein, antibody, and chimeric antibody or protein drug development services; Pharmaceutical peptide, protein, antibody, and chimeric antibodies or proteins product development; Pharmaceutical research and development of peptides, proteins, antibodies, and chimeric antibodies or proteins; Conducting early evaluations in the field of new peptide, protein, antibody, and chimeric antibody or protein based pharmaceuticals; Development of peptide, protein, antibody, and chimeric antibody or protein based pharmaceutical preparations and medicines; Laboratory peptide and protein based research services relating to pharmaceuticals; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development of peptide, protein, antibody, and chimeric antibody or protein based pharmaceuticals for the treatment of age-related diseases and cancer; Research in the field of peptide, protein, antibody, and chimeric antibody or protein based pharmaceuticals; Research on the subject of peptide, protein, antibody, and chimeric antibody or protein based pharmaceuticals; Technical research in the field of peptide, protein, antibody, and chimeric antibody or protein based pharmaceutical studies; Testing, inspection or research of pharmaceuticals, cosmetics or foodstuff made with peptides, proteins, antibodies, and chimeric antibodies or proteins; Research and development in the pharmaceutical and biotechnology fields; Research and development regarding pharmaceuticals, proteins, and antibodies; platform-as-a-service (PaaS) featuring computer software platforms for protein analysis and discovery of antibody-based drugs; Software as a service (SAAS) services featuring software for designing molecule libraries for the purposes of generating products in the field of pharmaceuticals, biotechnology, and medicine; Computer software development in the field of artificial intelligence, biotechnology, pharmaceuticals, and medical applications; Laboratory research services relating to pharmaceuticals; Medical and scientific research in the field of cancer treatment and diagnosis; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing on-line non-downloadable software using artificial intelligence for use in facilitating product development in the field of biotechnology, pharmaceuticals, and medicine; Scientific research for medical purposes in the area of cancerous diseases; Software as a service (SAAS) services featuring software using artificial intelligence for use in facilitating product development in the field of biotechnology, pharmaceuticals, and medicine; Technical consulting in the field of pharmaceutical studies; Technology consultation in the field of artificial intelligence; Testing of pharmaceuticals; Testing, inspection or research of pharmaceuticals, cosmetics or foodstuff; Providing medical testing services and information in the field of cancer research and disease classification; Providing information about medical research in the field of artificial intelligence, medical biotechnology, and pharmaceuticals

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 24, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 24, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 9, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jul 9, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 19, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 30, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 26, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 26, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 26, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 8, 2024 GNRN
NON-FINAL ACTION E-MAILED
Apr 8, 2024 GNRT
NON-FINAL ACTION WRITTEN
Apr 8, 2024 CNRT
ASSIGNED TO EXAMINER
Mar 25, 2024 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 28, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 28, 2023 CRFA
ASSIGNED TO LIE
Dec 28, 2023 ALIE
NOTICE OF DESIGN SEARCH CODE E-MAILED
Aug 18, 2023 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 17, 2023 NWOS
TEAS VOLUNTARY AMENDMENT RECEIVED
Aug 1, 2023 PARI
NEW APPLICATION ENTERED
Jul 22, 2023 NWAP